- Home
- RCKT vs ACTG Comparison
RCKT vs ACTG Comparison
Compare RCKT & ACTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- ACTG
- Stock Information
- Founded
- RCKT 1999
- ACTG 1993
- Country
- RCKT United States
- ACTG United States
- Employees
- RCKT N/A
- ACTG N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- ACTG Multi-Sector Companies
- Sector
- RCKT Health Care
- ACTG Miscellaneous
- Exchange
- RCKT Nasdaq
- ACTG Nasdaq
- Market Cap
- RCKT 328.6M
- ACTG 314.4M
- IPO Year
- RCKT N/A
- ACTG 1996
- Fundamental
- Price
- RCKT $3.19
- ACTG $3.34
- Analyst Decision
- RCKT Buy
- ACTG
- Analyst Count
- RCKT 13
- ACTG 0
- Target Price
- RCKT $12.96
- ACTG N/A
- AVG Volume (30 Days)
- RCKT 5.7M
- ACTG 180.7K
- Earning Date
- RCKT 11-06-2025
- ACTG 11-11-2025
- Dividend Yield
- RCKT N/A
- ACTG N/A
- EPS Growth
- RCKT N/A
- ACTG N/A
- EPS
- RCKT N/A
- ACTG N/A
- Revenue
- RCKT N/A
- ACTG $247,813,000.00
- Revenue This Year
- RCKT N/A
- ACTG $109.86
- Revenue Next Year
- RCKT $108.43
- ACTG N/A
- P/E Ratio
- RCKT N/A
- ACTG N/A
- Revenue Growth
- RCKT N/A
- ACTG 62.44
- 52 Week Low
- RCKT $2.19
- ACTG $2.70
- 52 Week High
- RCKT $22.01
- ACTG $5.36
- Technical
- Relative Strength Index (RSI)
- RCKT 47.80
- ACTG 49.71
- Support Level
- RCKT $3.09
- ACTG $3.13
- Resistance Level
- RCKT $3.29
- ACTG $3.40
- Average True Range (ATR)
- RCKT 0.16
- ACTG 0.13
- MACD
- RCKT -0.02
- ACTG 0.02
- Stochastic Oscillator
- RCKT 14.64
- ACTG 55.26
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
About ACTG Acacia Research Corporation (Acacia Tech)
Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, capital base, and deep industry relationships to drive value. The company has four reportable business segments: Intellectual Property Operations, Industrial Operations, Energy Operations and Manufacturing Operations. It derives revenue from Intellectual Property Operations segment. Geographically, it operates in Americas, Europe, Middle East and Africa, China, India, and Asia-Pacific, excluding China and India.